GoAI
Get started
Labcorp Holdings Inc. logo

Labcorp Holdings Inc.

LH

NYSEHealthcareMedical - Diagnostics & Research

Open in GoAI

Previous close

$336.34

+$3.53 · +1.06%

Aug 21, 4:00 PM ET

LH company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

93

Deep Value

Momentum

45

Neutral

Sentiment

51

Mixed

Risk resilience

80

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
US
CEO
Adam H. Schechter
Listed since
Mar 29, 1990
Employees
71,000

Market position

Day range

Current $336.34

52-week range

Current $336.34

Open
$333.5
Previous close
$332.81
Volume
418.3K
0.61× average
Average volume
680.96K
Average daily volume
Market cap
27.58B USD
Beta
0.84
Market reference 1
50-day average
$292.26
+15.08% above average
200-day average
$271.87
+23.71% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
27.54B USD
EV / EBITDA
13.69×
Earnings yield
4.20%
Free cash flow yield
5.78%

Profitability & efficiency

Return on equity
10.17%
Return on assets
4.77%
Return on invested capital
7.39%

Financial health

Current ratio
1.42×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends41%28%14%-0%Gross margin, FY2021: 38.01%Gross margin, FY2022: 31.26%Gross margin, FY2023: 27.67%Gross margin, FY2024: 27.86%Gross margin, FY2025: 26.75%Operating margin, FY2021: 23.21%Operating margin, FY2022: 12.11%Operating margin, FY2023: 5.97%Operating margin, FY2024: 8.35%Operating margin, FY2025: 10.87%Net margin, FY2021: 18.10%Net margin, FY2022: 10.78%Net margin, FY2023: 3.44%Net margin, FY2024: 5.73%Net margin, FY2025: 6.28%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 38.01%. Gross margin FY2022 31.26%. Gross margin FY2023 27.67%. Gross margin FY2024 27.86%. Gross margin FY2025 26.75%. Operating margin FY2021 23.21%. Operating margin FY2022 12.11%. Operating margin FY2023 5.97%. Operating margin FY2024 8.35%. Operating margin FY2025 10.87%. Net margin FY2021 18.10%. Net margin FY2022 10.78%. Net margin FY2023 3.44%. Net margin FY2024 5.73%. Net margin FY2025 6.28%.

Income trends

Revenue

13.95B USD+7.25%

Operating income

1.52B USD+39.52%

Net income

876.5M USD+17.49%
Income trends across reported periods15.31B USD9.89B USD4.48B USD−935.37M USDRevenue, FY2021: 13.14B USDRevenue, FY2022: 11.86B USDRevenue, FY2023: 12.16B USDRevenue, FY2024: 13.01B USDRevenue, FY2025: 13.95B USDOperating income, FY2021: 3.05B USDOperating income, FY2022: 1.44B USDOperating income, FY2023: 725.6M USDOperating income, FY2024: 1.09B USDOperating income, FY2025: 1.52B USDNet income, FY2021: 2.38B USDNet income, FY2022: 1.28B USDNet income, FY2023: 418M USDNet income, FY2024: 746M USDNet income, FY2025: 876.5M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 13.14B USD. Revenue FY2022 11.86B USD. Revenue FY2023 12.16B USD. Revenue FY2024 13.01B USD. Revenue FY2025 13.95B USD. Operating income FY2021 3.05B USD. Operating income FY2022 1.44B USD. Operating income FY2023 725.6M USD. Operating income FY2024 1.09B USD. Operating income FY2025 1.52B USD. Net income FY2021 2.38B USD. Net income FY2022 1.28B USD. Net income FY2023 418M USD. Net income FY2024 746M USD. Net income FY2025 876.5M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue13.95B USD13.01B USD12.16B USD11.86B USD13.14B USD
Cost of goods sold10.22B USD9.38B USD8.8B USD8.16B USD8.14B USD
Gross profit3.73B USD3.62B USD3.36B USD3.71B USD4.99B USD
Research and development——2M USD——
Selling, general, and administrative2.22B USD2.23B USD2.02B USD2B USD1.69B USD
Operating expenses2.22B USD2.54B USD2.64B USD2.27B USD1.94B USD
Interest income15.2M USD————
Interest expense224.1M USD208.3M USD199.6M USD179.8M USD211.8M USD
Depreciation and amortization681.1M USD643.5M USD577.3M USD537.2M USD577M USD
Operating income1.52B USD1.09B USD725.6M USD1.44B USD3.05B USD
Net income876.5M USD746M USD418M USD1.28B USD2.38B USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$324.43

3.54% downside
Past 12 months12-month forecastHigh $355Average $324.43Low $300

LH news

prnewswire.com

Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health

Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health Centers BURLINGTON, N.C. and BETHESDA, Md.

Read source
defenseworld.net

Labcorp (NYSE:LH) Sets New 12-Month High – Time to Buy?

Shares of Labcorp Holdings Inc. (NYSE: LH - Get Free Report) hit a new 52-week high during trading on Tuesday. The stock traded as high as $326.89 and last traded at $323.18, with a volume of 786484 shares changing…

Read source
prnewswire.com

Labcorp to Host Investor Day on September 10, 2026

BURLINGTON, N.C., Aug. 17, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September…

Read source
fool.com

Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million

The CEO liquidated 4,669 shares at a price of $320.37 per share, totaling ~$1.5 million on August 11, 2026. The transaction resulted in a 4% reduction of the executive's total equity holdings in the company.

Read source
zacks.com

Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?

LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view.

Read source
zacks.com

Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read source

LH peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding LH

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
807.52M
Weight
0.04%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard S&P 500 ETF logoVanguard S&P 500 ETFVOO
Market value
665.56M
Weight
0.04%
AUM
1.7T USD
Expense ratio
0.03%
Price / 1D
$703.71+0.39%
Vanguard Morningstar Mid-Cap ETF logoVanguard Morningstar Mid-Cap ETFVO
Market value
548.72M
Weight
0.24%
AUM
224.7B USD
Expense ratio
0.03%
Price / 1D
$82.97+0.53%
iShares Core S&P 500 ETF logoiShares Core S&P 500 ETFIVV
Market value
367.93M
Weight
0.04%
AUM
891.84B USD
Expense ratio
0.03%
Price / 1D
$769.31+0.39%
State Street SPDR S&P 500 ETF logoState Street SPDR S&P 500 ETFSPY
Market value
339.48M
Weight
0.04%
AUM
817.87B USD
Expense ratio
0.09%
Price / 1D
$765.72+0.41%
Vanguard Morningstar Value ETF logoVanguard Morningstar Value ETFVTV
Market value
241.6M
Weight
0.09%
AUM
256.5B USD
Expense ratio
0.03%
Price / 1D
$226.4+0.54%
Invesco S&P 500 Equal Weight ETF logoInvesco S&P 500 Equal Weight ETFRSP
Market value
231.37M
Weight
0.23%
AUM
100.27B USD
Expense ratio
0.20%
Price / 1D
$221.67+0.63%
State Street Health Care Select Sector SPDR ETF logoState Street Health Care Select Sector SPDR ETFXLV
Market value
196.32M
Weight
0.44%
AUM
44.76B USD
Expense ratio
0.08%
Price / 1D
$174.62+1.29%

Continue in GoAI

Research LH

research.disclaimer